Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study to Evaluate the Effect on Bone Mineral Density, and the Safety, of Quarterly Intravenous Bonviva in Patients With Post-menopausal Osteoporosis.

NCT00493532 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00493532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00493532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study to Evaluate the Effect on Bone Mineral Density, and the Safety, of Quarterly Intravenous Bonviva in Patients With Post-menopausal Osteoporosis.
Lead sponsor
Hoffmann-La Roche
Phase
Expanded access
Overall status
No longer available
Start date
June 30, 2007
Completion date
December 31, 2010
Enrollment
Not reported
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis